Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


PharmaZen notches strong increase in tough export market

PharmaZen notches strong increase in tough export market


3 April 2014 – Biotechnology company PharmaZen Ltd has reported a 38% increase in its annual surplus before tax of $739,114 for the year ended December 31, 2013, despite a challenging environment for exporters.

The result was on turnover of $6,998,599 and compares with a before tax surplus of $537,108 on turnover of $6,685,972 for the previous corresponding period.

Chief executive Craig McIntosh said it was a significant achievement in what was another challenging year for exporters.

He said PharmaZen had set very aggressive timetables for product and capability development as it looked for additional growth areas.

Last year saw the commercial launch of StimuCalä, a clinically proven calcium supplement.

“This is the first time the PharmZen has had branded material in retail markets and it is our first product with patent protection. StimuCalä is the only product on the market clinically proven not to cause spikes in calcium serum levels,” McIntosh said.

During the year, PharmaZen commissioned a state-of-the art fluidised powder blender enabling highly accurate blending at up to 1500kgs per batch.

McIntosh said the unit provided PharmaZen with a significant point of difference over competitors who had smaller, less-accurate ‘homogenizers’ and had already helped secure additional contract business.

After delays caused by a third party, the extraction plant will be commissioned this year and PharmaZen already has customer commitments for use.

“Frustrations that were outside our control with delays to the extraction project have prompted us to switch to a more self sufficient model and we have invested heavily in putting together a pilot plant that will be on a par with the best available in New Zealand,” McIntosh said.

“This provides a significant advantage as we will be able to offer pilot and scale up capacity across a range of technologies which will include spray drying, solvent extraction, freeze drying, and column separation. With this in mind we have bought a new 1000kg freeze dryer to cope with additional volumes and have an option on another larger unit.”

PharmaZen’s traditional freeze drying and vacuum drying technologies will be complemented in 2014 with the installation of a new Spray Dryer which opens up significant new product opportunities, McIntosh said.

“There is no doubt that exchange rates and margins will again prove challenging for 2014. However, through diversification of product range and increased capabilities, PharmaZen is well positioned.”

ENDS


© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

What Winter? Temperature Records Set For June 20-22

The days around the winter soltice produced a number of notably warm tempertaures. More>>

Conservation Deal: New Kākāpō Recovery Partnership Welcomed

Conservation Minister Maggie Barry says the new kakapo recovery partnership between DOC and Meridian Energy is great news for efforts to save one of New Zealand’s most beloved birds. More>>

ALSO:

Tech Sector Report: Joyce Warns Asian Tech Investors View NZ As Hobbits And Food

Speaking in Wellington at the launch of a report showcasing the value of the technology sector to the New Zealand economy, Joyce said more had to be done to tell the country's technology stories overseas. More>>

ALSO:

Mediaglommeration: APN Gets OIO Approval For Demerger Plan

APN News & Media has received Overseas Investment Office approval for its plan to split out its NZME unit ahead of a potential merger with rival Fairfax Media's New Zealand operations. More>>

New Paper: Ninety-Day Trial Period Has No Impact On Firms' Hiring

The introduction of a 90-day trial period has had no impact on hiring by New Zealand companies although they are now in widespread use, according to researchers at Motu Economic and Public Policy Research. More>>

ALSO:

Corrections: Serco Exits Equity Stake, Remains As Operator

Serco has sold its equity stake in the company that holds the contract to design, build and run Wiri Prison in South Auckland but continues as sub-contractor to operate the facility. More>>

GDP: NZ Economy Grows Faster-Than-Forecast 0.7%

New Zealand's economy grew at a faster pace than expected in the first quarter of 2016 as construction expanded at the quickest rate in two years. The kiwi dollar jumped after the data was released. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news